Flagship Pioneering
Venture capital firm · Founded 2000 · Cambridge, MA · Boston ↗
Cambridge firm founded in 2000 that originates and builds life-sciences companies through its Flagship Labs venture-creation model.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Flagship Pioneering, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$14B
Latest fund
Flagship Pioneering Fund VIII$2.6B · 2024
Funds
8
Check size
LAST CHECKED NOV 2026
Stages
SeedSeries ASeries B
Sectors
life sciencesbiotechhealth
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Modernaipo
Flagship-originated company; mRNA platform company that went public and became a decacorn.
Source: pharmaphorum.com
- Sana Biotechnologyipo
Flagship portfolio company that went public.
Source: pharmaphorum.com
- Foghorn Therapeuticsipo
Flagship portfolio company that went public.
Source: pharmaphorum.com
Misses
Track record
Partners 17
- Noubar Afeyan
Founder and CEO
Board seats
1 current
Ignacio MartinezGeneral Partner
Board seats
2 current
- Sophie de Boer
Senior Principal
Board seats
No public record - Christopher Austin
CEO-Partner
Board seats
No public record - Guillaume Pfefer
CEO-Partner
Board seats
No public record - Lovisa Afzelius
General Partner
Board seats
No public record - Michael Severino
CEO-Partner
Board seats
4 current
- Michelle Werner
CEO-Partner
Board seats
No public record - Paul Biondi
General Partner
Board seats
2 current
- Rob Rosiello
Executive Partner
Board seats
1 current
- Stephen Hahn
CEO-Partner
Board seats
No public record
Avak KahvejianGeneral Partner
Board seats
5 current
Show all 17 partners
- Doug Cole
Managing Partner
8 current
- Yvonne HaoNo public record
Chief Operating Officer and General Partner
- Angela Hwang
CEO-Partner
2 current
- Tuyen Ong
CEO-Partner
1 current
- Geoffrey von Maltzahn
General Partner
6 current
Reputation 1
No reputation score — basis not established for this firm.
- Flagship Fund VIII close
pharmaphorum.com
Contact
Published sources only
Published contact
- Website
- www.flagshippioneering.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Flagship Pioneering. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM $14B stated in fetched press coverage of Fund VIII close (July 2024), >=$10B Tier 1 threshold; also founded Moderna (decacorn/IPO). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Flagship Pioneering — provenance: GlassVC extended catalog, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation
- [2]
FIRM SITE · Flagship Pioneering — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
